Compare Proneuron Biotechnologies vs Spinal Modulation
Customers evaluate the quality of Proneuron Biotechnologies's products using the following success metrics.
Overview
Proneuron Biotechnologies is 28 yrs old and is based in United States.
Biopharmaceutical products for the of spinal cord injuries and other central nervous system disorders.
Spinal Modulation is based in United States
Spinal Modulation is dedicated to improving the lives of patients with chronic pain by providing the next generation of neuromodulation systems through stimulation of the dorsal root ganglion. The Spinal Modulation Axium Neurostimulator System is a next-generation intraspinal neuromodulation therapy that stimulates the dorsal root ganglion (DRG) to provide a new pain management option. It has shown promising results in managing chronic intractable leg pain, as well as difficult-to-target anatomy such as the back and foot.
Demo Video
Leadership
Nir Nimrodi (Chief Executive Officer)
David Wood (Chief Executive Officer, President)
Funding
Investors
DFJ Tamir Fishman Ventures, Infinity Fund
St. Jude Medical, Kleiner Perkins Caufield & Byers
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Proneuron Biotechnologies has not claimed their profile.
Work for Proneuron Biotechnologies? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Proneuron Biotechnologies?
Claim your profile now.
Information not available because Spinal Modulation has not claimed their profile.
Work for Spinal Modulation? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Spinal Modulation?
Claim your profile now.